Interface Biologics Financing Deal Gives A New Face to Biomedical Polymer Technology

At work developing transformative biomedical-polymer products, Interface Biologics, a private company, has recently completed a $7M series B financing led by Business Development Bank of Canada in conjunction with Covington Capital and VG Partners.

Read more »